000110796 001__ 110796
000110796 005__ 20240319080949.0
000110796 0247_ $$2doi$$a10.3390/healthcare10010160
000110796 0248_ $$2sideral$$a126696
000110796 037__ $$aART-2022-126696
000110796 041__ $$aeng
000110796 100__ $$aFernández-Sanchis, Daniel
000110796 245__ $$aCost-Effectiveness of Upper Extremity Dry Needling in Chronic Stroke
000110796 260__ $$c2022
000110796 5060_ $$aAccess copy available to the general public$$fUnrestricted
000110796 5203_ $$aIntroduction: Dry needling is a non-pharmacological approach that has proven to be effective in different neurological conditions. Objective: The aim of this study was to evaluate the cost-effectiveness of a single dry needling session in patients with chronic stroke. Methods: A cost-effectiveness analysis was performed based on a randomized controlled clinical trial. The results obtained from the values of the EuroQol-5D questionnaire and the Modified Modified Ashworth Scale were processed in order to obtain the percentage of treatment responders and the quality-adjusted life years (QALYs) for each alternative. The cost analysis was that of the hospital, clinic, or health center, including the equipment and physiotherapist. The cost per respondent and the incremental cost-effectiveness ratio of each alternative were assessed. Results: Twenty-three patients with stroke were selected. The cost of DN treatment was EUR 14.96, and the data analysis showed a favorable cost-effectiveness ratio of both EUR/QALY and EUR/responder for IG, although the sensitivity analysis using limit values did not confirm the dominance (higher effectiveness with less cost) of the dry needling over the sham dry needling. Conclusions: Dry needling is an affordable alternative with good results in the cost-effectiveness analysis—both immediately, and after two weeks of treatment—compared to sham dry needling in persons with chronic stroke.
000110796 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000110796 590__ $$a2.8$$b2022
000110796 592__ $$a0.55$$b2022
000110796 591__ $$aHEALTH POLICY & SERVICES$$b43 / 87 = 0.494$$c2022$$dQ2$$eT2
000110796 593__ $$aHealth Policy$$c2022$$dQ2
000110796 591__ $$aHEALTH CARE SCIENCES & SERVICES$$b57 / 106 = 0.538$$c2022$$dQ3$$eT2
000110796 593__ $$aLeadership and Management$$c2022$$dQ2
000110796 593__ $$aHealth Informatics$$c2022$$dQ3
000110796 593__ $$aHealth Information Management$$c2022$$dQ3
000110796 594__ $$a2.7$$b2022
000110796 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000110796 700__ $$aBrandín-de la Cruz, Natalia
000110796 700__ $$aJiménez-Sánchez, Carolina
000110796 700__ $$0(orcid)0000-0003-4792-1782$$aGil-Calvo, Marina$$uUniversidad de Zaragoza
000110796 700__ $$0(orcid)0000-0002-9201-0120$$aHerrero, Pablo$$uUniversidad de Zaragoza
000110796 700__ $$0(orcid)0000-0002-1674-7788$$aCalvo, Sandra$$uUniversidad de Zaragoza
000110796 7102_ $$11006$$2245$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Educación Física y Depor.
000110796 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000110796 773__ $$g10, 1 (2022), 160 [11 pp.]$$pHealthcare (Basel)$$tHealthcare (Switzerland)$$x2227-9032
000110796 8564_ $$s897710$$uhttps://zaguan.unizar.es/record/110796/files/texto_completo.pdf$$yVersión publicada
000110796 8564_ $$s2679896$$uhttps://zaguan.unizar.es/record/110796/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000110796 909CO $$ooai:zaguan.unizar.es:110796$$particulos$$pdriver
000110796 951__ $$a2024-03-18-12:51:21
000110796 980__ $$aARTICLE